Pathways in pathogenesis of PAH – Cardiology MCQ – Answer

Pathways in pathogenesis of PAH – Cardiology MCQ – Answer Which of the following is NOT a pathway involved in the pathogenesis of pulmonary arterial hypertension (PAH)? Correct answer: 4. Pentose phosphate pathway All the other three are important pathways in the pathogenesis of PAH. Medications used in the treatment block these pathways. Endothelin pathway blockers: Bosentan, Ambrisentan, Macitentan Nitric oxide pathway: Sildenafil, Tadalafil, Vardenafil Prostacyclin pathway: Epoprostenol, Iloprost, Treprostinil, Beraprost (Prostacyclin analogues) and Selexipag (Selective IP receptor antagonist). IP receptor is short for Prostaglandin I2 receptor or prostacyclin receptor. Back to question
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs